Bisoprolol tablets
Form: Tablet
Strength: 2.5 mg, 5 mg, 10 mg
Reference Brands: Zebeta, Monocor(US); Concor(EU)
Category: Heart Disorder
Bisoprolol tablets, marketed as Zebeta and Concor, are approved in the US by the FDA and in the EU via EMA for hypertension, angina, and heart failure. Regulatory approval requires a detailed dossier including clinical efficacy, safety data, manufacturing standards, and pharmacovigilance plans. The US FDA reviews clinical trial and quality data for timely approval, while the EMA ensures compliance with regional safety and manufacturing regulations. For guidance on dossier preparation, regulatory pathways, and market access, visit PharmaTradz. Regional compliance supports prompt approval, safe use, and broader availability, helping improve cardiovascular outcomes and quality of life worldwide.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Related Products
Aliskiren tablets
Strength: 150 mg, 300 mg
Form: Tablets
Reference Brands: Tekturna(US & EU)
View Details Get Enquiry
Atenolol tablets
Strength: 25 mg, 50 mg, 100 mg
Form: Tablets
Reference Brands: Tenormin(US)
View Details Get Enquiry
Metoprolol Tartrate tablet
Strength: IR: 25 mg, 50 mg, 100 mg; ER: 25 mg, 50 mg, 100 mg, 200 mg
Form: Tablets(IR & ER)
Reference Brands: US: Lopressor(IR); Toprol-XL(ER)
View Details Get Enquiry
Nifedipine tablets(IR/ER)
Strength: 10 mg, 20 mg, 30 mg, 60 mg, 90 mg (IR and ER forms)
Form: Tablet(IR & ER)
Reference Brands: Procardia(US);
View Details Get Enquiry